This short essay explores the 'rugged road ahead' for HIV/AIDS governance, with a focus on the intersection between intellectual property and access to essential medicines. It identifies promising changes that have taken place since the launch of the Doha Development Round of Trade Negotiations. It further highlights challenges that continue to haunt the HIV/AIDS governance regime while reducing access to essential medicines in developing countries.